AMGN Related Upgrades
-
Goldman Sachs Upgrades Amgen (AMGN) to Conviction Buy
-
Argus Upgrades Amgen (AMGN) to Buy
-
Deutsche Bank Upgrades Amgen (AMGN) to Buy, EPS Growth and Pipeline Offers Upside
-
UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)
-
UPDATE: UBS Upgrades Amgen (AMGN) to Buy; Pipeline Visibility Higher
-
Lazard Capital Upgrades Amgen (AMGN) to Buy
-
Piper Jaffray Upgrades Amgen (AMGN) to Overweight
-
Credit Suisse Upgrades Amgen (AMGN) to Outperform
-
Goldman Sachs Removes "Sell" From Amgen (AMGN) On Leadership Change
-
Goldman Sachs Adds Gilead Sciences (GILD) to the Conviction Buy List on Acquisition Strategy
-
Auriga Upgrades Affymax, Inc. (AFFY) to Buy, Raises Price Target By 50%
-
BofA/Merrill Lynch Upgrades Amgen (AMGN) to Neutral
-
Leerink Swann Upgrades Amgen (AMGN) to Outperform
-
Piper Jaffray Upgrades Amgen (AMGN) to Overweight
-
Soleil Upgrades Hologic (HOLX) to Buy, Starts Amgen (AMGN) at Buy
-
Argus Upgrades Amgen (AMGN) to Buy
-
Amgen (AMGN) Shares Upgraded to Buy at Argus; Stock Now Well Into Positive Territory
-
Citi Upgrades Amgen (AMGN) to Buy
-
UBS Upgrades Amgen (AMGN) to Buy
-
Bernstein Upgrades Amgen (AMGN) to Outperform
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)
-
Baird Upgrades Amgen (AMGN) To Outperform
-
JP Morgan Upgrades Amgen (AMGN) to Overweight
-
Benchmark Capital Upgrades Maxygen (MAXY) to Buy
-
William Blair Upgrades Amgen (AMGN) to Outperform
-
Citi Upgrades Amgen (AMGN) to Buy
-
Merrill Lynch Upgrades Amgen (AMGN) to Buy
-
Jefferies & Co. Upgrades Amgen (AMGN) to Buy
-
Rodman & Renshaw Upgrades Amgen (AMGN) to Market Outperform
-
Morgan Stanley Upgrades Amgen (AMGN) to Overweight
-
Lazard upgrades Amgen (AMGN) to Hold
-
Lehman Brothers upgrades Amgen (AMGN) to Overweight
-
Credit Suisse upgrades Amgen (AMGN) to Outperform
-
Merrill Lynch upgrades Amgen (AMGN) to Buy
-
UBS upgrades Amgen (AMGN) to Neutral
-
Bernstein Upgrades Amgen (AMGN) to Outperform
-
Citigroup Upgrades Amgen (AMGN) to Hold
-
Morgan Stanley upgrades Amgen (AMGN) to Overweight
-
Citigroup Upgrades ImClone Systems (IMCL) to Hold
-
Credit Suisse upgrades Amgen (AMGN) to Neutral
-
Bear Stearns upgrades Amgen Inc. (AMGN) to Outperform
-
Wachovia upgrades Amgen (AMGN) to Outperform
-
AG Edwards upgrades AMGN to Buy
-
UPDATE: Deutsche Bank upgrades AMGN to Buy
-
Deutsche Bank Upgrades AMGN
-
Hearing Deutsche Bank Upgraded AMGN to Buy
-
Piper Jaffray upgrades AMGN to Outperform
-
UBS upgrades AMGN to Buy
Back to AMGN Stock Lookup
